Sorcin: a novel potential target in therapies of cancers

Xinyi Zhou1, Xue Wu2, Baoan Chen2

  • 1Department of Hematology and Oncology, Zhongda Hospital, Medical School, Southeast University, Nanjing, Jiangsu Province, People's Republic of China.

Insights

Soluble resistance-related calcium-binding protein (sorcin) is linked to cell functions and various diseases. Overexpression of sorcin is associated with multidrug resistance (MDR) in cancer, suggesting it as a potential therapeutic target.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Soluble resistance-related calcium-binding protein (sorcin) is a penta-EF-hand protein found in human tissues.
  • Sorcin plays roles in calcium homeostasis, cell cycle regulation, and vesicle trafficking.
  • Altered sorcin expression is implicated in non-neoplastic diseases like diabetes and nervous system disorders.

Purpose of the Study:

  • To review the functions of sorcin.
  • To explore the role of sorcin in non-neoplastic and neoplastic diseases.
  • To discuss sorcin's relevance in drug resistance research.

Main Methods:

  • Literature review of existing research on sorcin.
  • Analysis of sorcin's expression patterns in various disease states.
  • Examination of studies linking sorcin to multidrug resistance (MDR).

Main Results:

  • Sorcin is widely distributed and involved in fundamental cellular processes.
  • Sorcin expression is associated with non-neoplastic conditions.
  • Sorcin overexpression is frequently observed in multidrug-resistant cancers.

Conclusions:

  • Sorcin's involvement in cellular functions and disease pathogenesis is significant.
  • Sorcin overexpression is strongly correlated with the development of multidrug resistance (MDR).
  • Sorcin represents a promising novel target for overcoming MDR in cancer therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles08:03

Anticancer Efficacy of Photodynamic Therapy with Lung Cancer-Targeted Nanoparticles

Photodynamic therapy (PDT) is an alternative choice for lung cancer treatment. To increase the therapeutic effect of PDT, lung cancer-targeted nanoparticles combined with chemotherapy were developed. Both in vitro and in vivo anticancer efficacies of PDT with prepared nanoparticles were...
9.5K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.9K
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts10:27

Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

Here we present a protocol to test the efficacy of targeted therapies selected based on the genomic makeup of a tumor. The protocol describes identification and validation of structural DNA rearrangements, engraftment of patients’ tumors into mice and testing responses to corresponding...
7.8K
Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring08:45

Cerenkov Luminescence Imaging (CLI) for Cancer Therapy Monitoring

Use of Cerenkov Luminescence Imaging (CLI) for monitoring preclinical cancer treatment is described here. This method takes advantage of Cerenkov Radiation (CR) and optical imaging (OI) to visualize radiolabeled probes and thus provides an alternative to PET in preclinical therapeutic monitoring and drug...
14.3K
A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease07:17

A Murine Ommaya Xenograft Model to Study Direct-Targeted Therapy of Leptomeningeal Disease

Here, we describe a murine xenograft model that functionally resembles an Ommaya reservoir in patients. We developed the Murine Ommaya to study novel therapeutics for the universally fatal leptomeningeal...
6.4K